Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› India
Clinical trial register · India

Clinical Trials in India

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1122 matching records held by the registry are in this view. Synced 06 Nov 2026, 03:16 UTC
1122
Studies in scope
all four open statuses
608
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
New Delhi 340 Mumbai 261 Hyderabad 233 Bangalore 199 Pune 186
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca102 Institute of Liver and Biliary Sciences, India49 Novartis Pharmaceuticals44 Tata Memorial Centre42 Postgraduate Institute of Dental Sciences Rohtak42
Site location
New Delhi340 Mumbai261 Hyderabad233 Bangalore199 Pune186
All 276 locations
Target enrolment
to

Trials in this register

1122 of 1122 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Recruiting
RCT of EFTR Versus STER for GIST Treatment
NCT07411118Small Size Gastrointestinal Stromal Tumors, GIST
Chinese University of Hong Kong
Not applicable
136
Hyderabad
2025-02-01
Not yet open
Institute of Liver and Biliary Sciences, India
Not applicable
100
New Delhi
2025-01-31
By invitation
Novo Nordisk A/S
Observational
244
Bangalore
2025-01-31
Not yet open
Institute of Liver and Biliary Sciences, India
Phase 2/3
120
New Delhi
2025-01-31
Recruiting
Pfizer
Observational
50
Bengaluru, Chennai, Coimbatore, Madurai
2025-01-30
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Madurai, Sūrat
2025-01-28
Recruiting
Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients
NCT07724873Hematopoietic Stem Cell Transplant (HSCT), GVHD - Graft-Versus-Host Disease, Hematological Malignancy
Tata Memorial Centre
Phase 1/2
54
Navi Mumbai
2025-01-28
Not yet open
Institute of Liver and Biliary Sciences, India
Observational
150
New Delhi
2025-01-25
Not yet open
Institute of Liver and Biliary Sciences, India
Phase 2/3
96
New Delhi
2025-01-25
Recruiting
Pfizer
Phase 3
211
Gurugram, Ernākulam
2025-01-22
Not yet open
Institute of Liver and Biliary Sciences, India
Not applicable
60
New Delhi
2025-01-20
Not yet open
Institute of Liver and Biliary Sciences, India
Not applicable
220
New Delhi
2025-01-20
Recruiting
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors
NCT06549673Portal Hypertension, Cirrhosis, Varices, Esophageal
Chinese University of Hong Kong
Observational
375
Hyderabad, New Delhi
2025-01-20
Recruiting
mHealth India Postnatal Health Intervention Effectiveness
NCT05268588Health Knowledge, Attitudes, Practice, Post Partum Depression, Breastfeeding, Nutrition, Healthy
University of California, San Francisco
Not applicable
2,100
Chandīgarh, Bhopal, New Delhi
2025-01-20
Recruiting
LIFT-UP: Randomized Controlled Trial of Fortification of Human Milk
NCT06765863Very Preterm Infant, Very Low Birthweight
Harvard School of Public Health (HSPH)
Not applicable
776
Ballary, Belagavi, Davangere, Hyderabad
2025-01-16
Not yet open
Postgraduate Institute of Dental Sciences Rohtak
Observational
200
Rohtak
2025-01-15
Recruiting
Shortened Regimen for Drug-susceptible TB in Children
NCT06253715Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Lymph Node, Mycobacterium Tuberculosis
DrugsRifapentine·Rifampin·Pyrazinamide·Isoniazid
Johns Hopkins University
Phase 3
860
Chennai, Pune
2025-01-15
Recruiting
Aurigene Discovery Technologies Limited
Phase 1
40
Vadodara, Jhajjar, Bangalore, Chhatrapati Sambhajinagar, Nagpur, Pune, Satara, Thane
2025-01-15
Recruiting
Novo Nordisk A/S
Phase 3
480
Raipur, Mumbai, Bangalore, Gujarat, Maharashtra, New Delhi
2025-01-10
Recruiting
Tracing Brain Tumors Through Deep Time
NCT06381531Brain Tumor, Oncology
Tata Memorial Centre
Observational
10,000
Mumbai
2025-01-10
Active, closed
Janssen Research & Development, LLC
Phase 3
813
Ahmedabad, Bhubaneswar, Hubballi, Kolkata, Mysuru, New Delhi, Noida, Surat
2025-01-09
Active, closed
Pfizer
Phase 3
1,035
Surat, Gurugram, Bangalore, Mumbai, Nashik, Pune, Thane, New Delhi
2025-01-06
Not yet open
Institute of Liver and Biliary Sciences, India
Not applicable
100
New Delhi
2025-01-05
Not yet open
Testing and Comparing the Impacts of Mhealth-Based and Web-Based Education on Oral Cancer
NCT06711848Oral Cancer, Health Education, Community, Digital Intervention, MHealth Application
University of Rwanda
Not applicable
75
Tamil Nadu
2025-01-05
Recruiting
FAPi PET in Pancreatic Ductal Adenocarcinoma
NCT07342231Pancreatic Cancer, Adenocarcinoma Pancreas
Tata Memorial Hospital
Observational
60
Mumbai
2025-01-04
By invitation
Sichuan Credit Pharmaceutical Co., Ltd.
Not applicable
14
Hyderabad
2025-01-03
Recruiting
Tata Memorial Centre
Not applicable
32
Mumbai
2025-01-03
Recruiting
Innovative Multidisciplinary Strategies for Combating Severe Dengue
NCT06751836DENV Without Warning Signs, DENV with Warning Signs, Severe Dengue, Healthy Controls Group - Age and Sex-matched
Karolinska Institutet
Observational
1,400
Mangalore
2025-01-03
Active, closed
AstraZeneca
Phase 4
100
Bangalore, Delhi, Kochi, Mumbai, New Delhi, Pune, Varanasi
2025-01-02
Recruiting
Rajiv Gandhi Cancer Institute & Research Center, India
Phase 3
114
Delhi
2025-01-01
Recruiting
Institute of Liver and Biliary Sciences, India
Not applicable
60
New Delhi
2025-01-01
Not yet open
Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD
NCT06749704Metabolic Dysfunction Associated Fatty Liver Disease
Institute of Liver and Biliary Sciences, India
Not applicable
140
Delhi
2024-12-27
Recruiting
All India Institute of Medical Sciences, Jodhpur
Phase 3
346
Bhubaneswar, Jodhpur, Bathinda, Dehradun, Lucknow, Rishikesh, Udaipur
2024-12-20
Recruiting
GlaxoSmithKline
Phase 3
520
Ahmedabad, Bangalore, Hyderabad, Kolkata, Pune, Sushrut Hospital and Research
2024-12-16
Active, closed
Kirby Institute
Phase 3
300
Chennai
2024-12-16
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Delhi, Hyderabad, Kolkata, Mumbai, New Delhi, Pune, Varanasi, Vellore
2024-12-12
Active, closed
Hoffmann-La Roche
Phase 3
350
Surat, Nagpur (urban), Jaipur, Secunderabad
2024-12-11
Recruiting
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
80
Chandigarh
2024-12-11
Recruiting
Novo Nordisk A/S
Phase 2
465
Guntur, Bengaluru, Kozhikode, Jaipur, Hyderabad
2024-12-02
Recruiting
Institute of Liver and Biliary Sciences, India
Not applicable
100
New Delhi
2024-12-01
Active, closed
Assessing the Effects of Cool Roofs on Mental Health in Ahmedabad, India
NCT07251218Eco-anxiety, PTSD - Post Traumatic Stress Disorder, Resilience, Anxiety
Aditi Bunker
Not applicable
800
Ahmedabad
2024-12-01
Recruiting
ICU-related Out of Pocket Expenses (ICOPE)
NCT07439692Cost of ICU, Out of Pocket Expenses
Nat Intensive Care Surveillance - MORU
Observational
354
Mysore, Kochi, Pune, New Delhi, Chennai
2024-12-01
Active, closed
Tata Memorial Hospital
Observational
300
Mumbai, Navi Mumbai
2024-11-28
Active, closed
EyePoint Pharmaceuticals, Inc.
Phase 3
400
Ahmedabad, Kolkata, Miraj, Mumbai, Varanasi
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Calicut, Delhi, Gūrgaon, Kolkata, Madurai, Mumbai, Nashik, New Delhi
2024-11-27
Recruiting
The Health and Social Consequences of Depression Among the Elderly
NCT05856552Depression, Functional Impairment
National Bureau of Economic Research, Inc.
Not applicable
5,370
Chennai
2024-11-20
Active, closed
Meenakshi Ammal Dental College and Hospital
Not applicable
84
Chennai
2024-11-20
Recruiting
All India Institute of Medical Sciences
Not applicable
150
Delhi, New Delhi
2024-11-20
Recruiting
AstraZeneca
Phase 3
1,160
Calicut, Delhi, Gūrgaon, Kolkata, Madurai, Mumbai, Nagpur, Nashik
2024-11-18
Recruiting
St. John's Research Institute
Phase 2/3
120
Bangalore
2024-11-15
Active, closed
Pfizer
Phase 3
636
Gurugram, Mangalore, Nashik, New Delhi
2024-11-15
Active, closed
Automated Arthritis Detection Using Artificial Intelligence on Smartphone Photographs
NCT06715488Rheumatoid Arthritis &Amp; Other Inflammatory Polyarthropathies, Peripheral Spondyloarthritis, Inflammatory Arthritis
Med2Measure
Observational
3,000
Pune
2024-11-15
Recruiting
GlaxoSmithKline
Phase 3
324
Ahmedabad, Bikaner, Kolkata, Mumbai, Surat
2024-11-13
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Ahemdabad, Chandigarh, Hyderabad, Afzalgunj, Jaipur, Lucknow, Nagpur, New Delhi, Rohtak
2024-11-12
Not yet open
Institute of Liver and Biliary Sciences, India
Observational
50
New Delhi
2024-11-10
Not yet open
Institute of Liver and Biliary Sciences, India
Not applicable
20
New Delhi
2024-11-10
Recruiting
University of Pittsburgh
Not applicable
96
Bengaluru
2024-11-01
Not yet open
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
100
Chandigarh
2024-11
Recruiting
Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
NCT07709195Oral Mucositis, Total Body Irradiation, Hematological Malignancies, Hematopoietic Stem Cell Transplantation (HSCT)
DrugChlorophyllin
Tata Memorial Centre
Phase 2
17
Navi Mumbai
2024-10-30
Recruiting
Asian Watch-and-Wait Database (AWWD)
NCT06631443Rectal Adenocarcinoma, Rectal Cancer
Tata Memorial Centre
Observational
337
Mumbai
2024-10-22
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Delhi, Kolkata, Mumbai, Pune, Varanasi
2024-10-18
Recruiting
Tata Memorial Centre
Phase 2
22
Navi Mumbai
2024-10-18
Recruiting
The Archer-Daniels-Midland Company
Not applicable
126
Vadodara, Nashik, Pune, Sopāra, Vasai
2024-10-15
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Ahemdabad, Chandigarh, Hyderabad, Afzalgunj, Jaipur, Lucknow, Mohali, Nagpur, New Delhi
2024-10-14
Active, closed
Novartis Pharmaceuticals
Phase 2
201
Kochi, Mumbai, New Delhi, Jaipur
2024-10-09
Recruiting
Bristol-Myers Squibb
Phase 3
1,000
Badsa, Bengaluru, Thiruvananthapuram, Mumbai, New Delhi, Secunderabad, Varanasi, Howrah
2024-10-07
Active, closed
AstraZeneca
Phase 3
768
Hyderabad, Kolhāpur, Mumbai, Namakkal, Pune, Ranchi, Thane, Varanasi
2024-10-04
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Hyderabad, Surat, Vadodara, Mysore, Thiruvananthapuram, Mumbai, Nagpur, Pune
2024-10-04
Recruiting
Spatially Fractionated Radiation Treatment for Gynaecological Cancers
NCT06644846Cervical Cancer, Gynecologic Cancer, Recurrent Cancer
Tata Memorial Hospital
Not applicable
20
Navi Mumbai
2024-10-04
By invitation
Sanofi
Phase 2
900
Calicut, Hyderabad, Kanpur, Nagpur, Pune
2024-09-30
Active, closed
Regeneron Pharmaceuticals
Phase 2
19
Ahmedabad, Surat, Kochi, Mumbai, New Delhi, Jaipur
2024-09-30
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Chhatrapati Sambhajinagar, Nagpur, Chandigarh, Ajmer, Hyderabad, Kolkata, Varanasi
2024-09-26
Active, closed
Boehringer Ingelheim
Phase 3
1,666
Mumbai
2024-09-26
Recruiting
Pfizer
Phase 2
48
Surat, Bengaluru, Pune, Lucknow, Kolkata
2024-09-25
Recruiting
Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers
NCT07337850Gall Bladder Cancer, Intrahepatic Cholangiocarcinoma (Icc)
Tata Memorial Centre
Observational
60
Mumbai
2024-09-25
Active, closed
Hoffmann-La Roche
Phase 3
400
Surat, Jaipur
2024-09-17
Recruiting
Asian Institute of Gastroenterology, India
Not applicable
500
Hyderabad
2024-09-14
Recruiting
Assessing the Effects of Cool Roofs on Indoor Environments and Health
NCT06579950Resting Heart Rate, Blood Glucose Control, Depression, Heat-related Symptoms
Aditi Bunker
Not applicable
3,200
Ahmedabad
2024-09-04
Active, closed
Assessing the Effect of Cool Roofs on Health Using Smartwatches
NCT06579963Heart Rate, All-day Steps, Distance Walked, Active Minutes
Aditi Bunker
Not applicable
800
Ahmedabad
2024-09-04
Recruiting
The George Institute
Phase 3
2,000
Visakhapatnam, Patna, Raipur, Dehradun, Ahmedabad, Vadodara, Mangaluru, Meppādi
2024-09-04
Recruiting
Dr. Shalini Gupta
Not applicable
315
New Delhi
2024-09-01
Recruiting
University of Pittsburgh
Not applicable
168
Bengaluru, Bhubaneswar
2024-08-31
Active, closed
Boehringer Ingelheim
Phase 3
8,371
Bangalore, Bathinda, Bhubaneswar, Bilāspur, Chandigarh, Chennai, Dwārka, Faridabad
2024-08-30
Recruiting
Takeda
Phase 4
124
Vijayawada, Guwahati, Surat, Bangalore, Puducherry, Nashik, Navi Mumbai, Pune
2024-08-28
Recruiting
Jubilant Therapeutics India Limited
Phase 1
30
Surat, Bangalore, Mumbai, Nashik, Thane, New Delhi
2024-08-26
Recruiting
Effect of Yoga in Chronic Insomnia
NCT07419152Chronic Insomnia
All India Institute of Medical Sciences
Not applicable
72
New Delhi
2024-08-14
By invitation
Bioagile Therapeutics Pvt. Ltd.
Not applicable
170
Chandigarh, Panjagutta, Chowk, Mumbai, Delhi, Vasant Kunj
2024-08-13
Recruiting
AstraZeneca
Phase 3
620
Dehradun, Delhi, Kanpur, Kolkata, Mumbai, Vadodara, Varanasi
2024-08-12
Recruiting
Asian Institute of Gastroenterology, India
Observational
74
Hyderabad
2024-08-10
Not yet open
Tata Medical Center
Not applicable
600
Kolkata
2024-08-07
Recruiting
AstraZeneca
Phase 3
1,018
Delhi, Gurugram, Kolkata, Nashik, Surat, Thiruvananthapuram
2024-08-07
Active, closed
Utilization of Maternal Healthcare Services and Infant Feeding Practices
NCT06601439Maternal Health, Prenatal Care, Feeding Patterns
Hirabai Cowasji Jehangir Medical Research Institute
Observational
500
Pune
2024-08-05
Recruiting
Drain vs No Drain After Live Donor Hepatectomy
NCT06769776Donor Hepatectomy
Marengo Asia Hospitals
Not applicable
80
Faridabad
2024-08-02
Recruiting
Tata Memorial Centre
Phase 2
166
Navi Mumbai
2024-08-02
Recruiting
AstraZeneca
Phase 3
788
Delhi, Kolkata, Lucknow, Mumbai, Mysuru, Nagpur, Nashik, New Delhi
2024-08-01
By invitation
Biohaven Therapeutics Ltd.
Phase 2
660
Hyderabad, Mangalore, Mumbai, Nagpur, New Delhi
2024-07-30
Recruiting
Jazz Pharmaceuticals
Phase 3
286
Belagavi, Mumbai, Nashik, Hyderabad, Varanasi, New Delhi
2024-07-19
Active, closed
Celldex Therapeutics
Phase 3
976
Surat, Vadodara, Nagpur, Nashik, Pune, Jaipur, Kanpur, Ahmedabad
2024-07-19
Recruiting
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
385
Ahmedabad, Bhubaneswar, Coimbatore, Jaipur, Kochi, Ludhiana, New Delhi, Pune
2024-07-18
Recruiting
Fibrosis Lessens After Metabolic Surgery
NCT06374875Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD), Non-Alcoholic Fatty Liver Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Liver Fibrosis
The Cleveland Clinic
Phase 4
120
Indore, Mumbai
2024-07-11
Active, closed
mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal
NCT03700034Gestational Diabetes Mellitus (GDM), Pregnancy Induced Hypertension (PIH), Anemia
Public Health Foundation of India
Not applicable
1,320
Medak, Rangareddy, Siddipet, Vikārābād, Yadadri Bhuvnagiri
2024-07-10
Recruiting
Colorado Prevention Center
Phase 3
1,500
Ahmedabad, Bangalore, Nagpur, New Delhi
2024-07-09
Recruiting
Short Versus Long-term Levetiracetam in Brain Tumors
NCT06442748Seizures, Brain Tumors, Antiepileptics, Levetiracetam
DrugLevetiracetam
Tata Memorial Centre
Phase 3
604
Udupi, Mumbai
2024-07-04
Recruiting
AO Innovation Translation Center
Observational
600
Patna
2024-07-03
Recruiting
Study of WAL0921 in Patients With Glomerular Kidney Diseases
NCT06466135Diabetic Nephropathies, Primary Focal Segmental Glomerulosclerosis, Minimal Change Disease, Primary Immunoglobulin A Nephropathy
Walden Biosciences
Phase 2
96
Raipur, Nadiād, Vadodara, Bangalore, Pune, Sambhajinagar, New Delhi, Patparganj
2024-07-02
Recruiting
Parasitic Ulcer Treatment Trial
NCT06213649Acanthamoeba Keratitis
DrugProntosan
Jeremy Keenan, MD, MPH
Phase 3
232
Coimbatore, Madurai
2024-07-01
Active, closed
University of California, San Francisco
Phase 3
60
Madurai
2024-07-01
Recruiting
Krishnadevaraya College of Dental Sciences & Hospital
Phase 1
36
Bengaluru
2024-07-01
Recruiting
Nemours Children's Clinic
Not applicable
800
Belagavi, Chandrapur, Nagpur, Pune, Wardha, Jaipur, Hyderabad
2024-07-01
Recruiting
Panafina, Inc.
Phase 2
36
Kochi, Vellore, Chandigarh, Delhi, New Delhi
2024-06-28
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Guntur, Visakhapatnam, Raipur, Ahmedabad, Surat, Vadodara, Bengaluru, Mangaluru
2024-06-25
By invitation
Hirabai Cowasji Jehangir Medical Research Institute
Observational
400
Pune
2024-06-25
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Hyderabad, Bangalore, Mangalore, Nashik, Pune
2024-06-25
Recruiting
AstraZeneca
Phase 3
240
Ahmedabad, Bangalore, Dehradun, Delhi, Gurugram, Hyderabad, Kolkata, Lucknow
2024-06-20
Active, closed
Celgene
Phase 3
850
Belagavi, Kochi, Mumbai, New Delhi, Howrah, New Town
2024-06-19
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bangalore, Bengaluru, Bikaner, Chennai, Chhatrapati Sambhajinagar, Guwahati, Gūrgaon, Kochi
2024-06-17
Active, closed
University of Pittsburgh
Not applicable
104
Bengaluru
2024-06-15
Recruiting
Duk-Woo Park, MD
Not applicable
1,500
Bathinda, Gurugram, New Delhi
2024-06-14
Recruiting
Community Health Worker-Led Postpartum Diabetes Screening
NCT06209411Diabetes Mellitus, Type 2, Gestational Diabetes
Weill Medical College of Cornell University
Not applicable
330
Pune
2024-06-13
Active, closed
Merck Sharp & Dohme LLC
Phase 3
550
Gurugram, Mumbai, New Delhi
2024-06-11
Active, closed
GlaxoSmithKline
Phase 3
88
Gokul Shirgoan, Apex Wellness Hospital, Bangalore, Belagavi, Bhubaneswar, Gūrgaon, New Delhi
2024-06-10
Recruiting
X4 Pharmaceuticals
Phase 3
176
Patna, Surat, Udaipur, Hyderabad
2024-06-06
Recruiting
Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
NCT06394232Retinal Disease, Macular Degeneration, Age-Related Macular Degeneration, Geographic Atrophy
DrugTacrolimus
Eyestem Research Pvt. Ltd.
Phase 1/2
54
Jālna, Delhi, Hyderabad
2024-06-04
Recruiting
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
196
Chandigarh
2024-06-03
Recruiting
All India Institute of Medical Sciences
Not applicable
60
Delhi, New Delhi
2024-06-01
Recruiting
Merck Sharp & Dohme LLC
Phase 3
348
Mumbai, New Delhi
2024-05-24
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,800
Gujrāt, Prayagraj, Rajpur Sonarpur, Sūrat, Wardha
2024-05-24
Recruiting
Postgraduate Institute of Dental Sciences Rohtak
Not applicable
159
Haryāna
2024-05-23
Recruiting
Postgraduate Institute of Dental Sciences Rohtak
Not applicable
30
Haryāna
2024-05-23
Recruiting
Postgraduate Institute of Dental Sciences Rohtak
Not applicable
106
Rohtak
2024-05-23
Recruiting
Novartis Pharmaceuticals
Phase 3
550
Ahmedabad, Kozhikode, Kolhāpur, Nagpur, Nashik, Pune, New Delhi
2024-05-21
Recruiting
University of Pittsburgh
Not applicable
32
Bengaluru
2024-05-17
Recruiting
Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy
NCT06926543Invasive Breast Cancer, Stage III Breast Cancer, Stage IIB Breast Cancer
Dr. Tabassum Wadasadawala
Phase 3
858
Vishkhapatnam, Mumbai, New Chandigarh, Sangrur, Varanasi
2024-05-14
Recruiting
Intra-Cellular Therapies, Inc.
Phase 3
384
Ahmedabad, Chhatrapati Sambhajinagar, Nashik, Varanasi
2024-05-14
Active, closed
Biohaven Therapeutics Ltd.
Phase 2/3
390
Hyderabad, Mangalore, Mumbai, Nagpur, New Delhi
2024-05-13
Recruiting
Asian Institute of Gastroenterology, India
Not applicable
200
Hyderabad
2024-05-11
Active, closed
Sanofi
Phase 3
1,541
Ahmedabad, Belagavi, Chandigarh, Faridabad, Kolkata, Nagpur, Pune
2024-05-08
Recruiting
Novartis Pharmaceuticals
Phase 3
65
Nagpur, Pune
2024-05-08
Recruiting
Institute of Liver and Biliary Sciences, India
Observational
250
Guindy, Ahmedabad, Surat, Srinagar, Bengaluru, Mangalore, Kochi, Thiruvananthapuram
2024-05-02
Active, closed
Eli Lilly and Company
Phase 3
10,000
Allahabād, Bangalore, Bhubaneswar, Bikaner, Chennai, Dehradun, Guntur, Kanpur
2024-04-30
Recruiting
Octapharma
Phase 3
124
Pune, Bangalore, Chhatrapati Sambhajinagar, Patna
2024-04-30
Recruiting
AstraZeneca
Phase 3
582
Bangalore, Delhi, Hyderabad, Kolkata, Mysuru, Nagpur, Nashik, New Delhi
2024-04-29
Recruiting
Seung-Jung Park
Not applicable
960
Bangalore
2024-04-25
Recruiting
"One All" to Get it RYT (Resilient Young Tribal Adults)
NCT06474260Healthy Human Volunteers, Youth Resilience
University of Pittsburgh
Not applicable
240
Chamrajnagar, Gudalur
2024-04-22
Active, closed
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
NCT06256432Hepatorenal Syndrome, Liver Cirrhosis, Acute Kidney Injury, Ascites Hepatic
DrugsAmbrisentan·Terlipressin
Noorik Biopharmaceuticals AG
Phase 2
54
Bangalore, Mumbai, New Delhi, Hyderabad, Kanpur, Lucknow
2024-04-17
Active, closed
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.
NCT06372145Relapsing Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis
DrugTeriflunomide
Sanofi
Phase 3
2,500
Bengaluru, Chandigarh, Delhi, Gūrgaon, Mangaluru, Nagpur, New Delhi, Thiruvananthapuram
2024-04-16
Active, closed
University of California, San Francisco
Not applicable
2,400
Udaipur
2024-04-15
Not yet open
Lesioning Procedures for Movement Disorders
NCT06352268Dystonia, Parkinson Disease, Essential Tremor
All India Institute of Medical Sciences
Observational
250
New Delhi
2024-04-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Mumbai, New Delhi
2024-04-14
Recruiting
AstraZeneca
Phase 3
3,850
Ahmedabad, Ajmer, Amritsar, Bangalore, Belagavi, Coimbatore, Dehradun, Delhi
2024-04-12
Recruiting
AstraZeneca
Phase 3
675
Chennai, Dwārka, Jaipur, Kolkata, Marg Jaipur, Nagpur, Nashik, New Delhi
2024-04-11
Recruiting
International Extranodal Lymphoma Study Group (IELSG)
Observational
300
Mumbai
2024-04-11
Recruiting
McGill University Health Centre/Research Institute of the McGill University Health Centre
Not applicable
110
Hyderabad
2024-04-09
Recruiting
Dose Escalation Using Hypoxia-adjusted Radiotherapy
NCT06087614Head and Neck Squamous Cell Carcinoma
DrugCisplatin
Rajiv Gandhi Cancer Institute & Research Center, India
Phase 2
124
Delhi
2024-04-08
Active, closed
Asian Institute of Gastroenterology, India
Observational
100
Hyderabad
2024-04-05
Active, closed
TWi Biotechnology, Inc.
Phase 2/3
80
Chandigarh
2024-04-04
Recruiting
All India Institute of Medical Sciences
Phase 2/3
396
Jhajjar
2024-04-03
Active, closed
Novo Nordisk A/S
Phase 3
673
Vijayawada, Visakhapatnam, Vadodara, Belagavi, Bengaluru, Mysuru, Udupi, Nagpur
2024-04-01
Active, closed
Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)
NCT05983471Idiopathic Pulmonary Fibrosis, Cough, IPF, Fibrotic Lung Disease
Melius Pharma AB
Phase 2
40
Guntur, Belagavi, Pune, Coimbatore, Kanpur, Kolkata
2024-04-01
Active, closed
GSVM Medical College
Not applicable
100
Kanpur
2024-04-01
Active, closed
GSVM Medical College
Not applicable
60
Kanpur
2024-04-01
Recruiting
Conventional Vs Tailored Limb Lengths in Laparoscopic Roux-en Y Gastric Bypass Surgery
NCT06756789Obesity, Metabolic Disease, Bariatric Surgery Candidate, Metabolic Surgery
GEM Hospital & Research Center
Not applicable
40
Coimbatore
2024-04-01
Active, closed
GSVM Medical College
Not applicable
60
Kanpur
2024-04-01
Active, closed
AstraZeneca
Phase 3
2,554
Bangalore, Belagavi, Calicut, Chennai, Coimbatore, Dehradun, Hyderabad, Kolkata
2024-03-29
Recruiting
GlaxoSmithKline
Phase 3
864
Mumbai, Pune, Bengaluru, Bhubaneswar, Gūrgaon, Hyderabad, Nashik, Nehru Nagar Belagavi Karnataka 590010
2024-03-21
Active, closed
Harvard Medical School (HMS and HSDM)
Phase 3
1,500
Bhopal
2024-03-18
Not yet open
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 2/3
130
Chandigarh
2024-03-15
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
Hoffmann-La Roche
Phase 3
1,350
Guwahati, Allahābād, Kolkata, Bhubaneswar, Gujrāt, Nagpur, New Delhi, Surat
2024-03-13
Active, closed
Samsung Bioepis Co., Ltd.
Phase 3
555
Bangalore, Bhubaneswar, Erandwane, Hyderabad, Jaipur, Mumbai, Sūrat, Udaipur
2024-03-12
Recruiting
Tata Memorial Centre
Phase 2/3
249
Mumbai
2024-03-07
Recruiting
NYU Langone Health
Not applicable
255
Thiruvananthapuram, Delhi, Ludhiana
2024-03-06
Active, closed
Eli Lilly and Company
Phase 3
17,300
Belagavi, Bikaner, Dehradun, Kanpur, Kochi, Kozhikode, Lucknow, Nashik
2024-03-05
Recruiting
Rhizen Pharmaceuticals SA
Phase 2
40
Vijayawada, Bangalore, Mumbai, Pune, Madurai, Hyderabad, Kolkata
2024-03-04
Active, closed
AstraZeneca
Phase 3
594
Ahmedabad, Hyderabad, Mumbai, New Delhi
2024-03-04
Not yet open
Institute of Liver and Biliary Sciences, India
Not applicable
190
New Delhi
2024-03-01
Not yet open
Indian Council of Medical Research
Phase 3
372
Chennai
2024-03
Recruiting
Teachers Leading the Front Lines - Adolescent
NCT06248203Adolescent Behavior, Adolescent - Emotional Problem, Mental Health Issue, Psychosocial Functioning
University of North Carolina, Chapel Hill
Not applicable
216
Darjeeling
2024-02-29
Active, closed
Novartis Pharmaceuticals
Phase 3
1,466
Hyderabad, Bangalore, Mumbai, Pune, New Delhi, Bhubaneswar, Chennai, Kolkata
2024-02-28
Recruiting
University of Edinburgh
Observational
1,332
Manali, Pādhar, Ludhiana
2024-02-28
Recruiting
Tata Memorial Centre
Phase 3
101
Mumbai
2024-02-22
Recruiting
AstraZeneca
Phase 3
5,250
Ahmedabad, Aligarh, Belagavi, Calicut, Chandigarh, Dehradun, Delhi, Dwārka
2024-02-21
Recruiting
Novartis Pharmaceuticals
Phase 2
108
Belagavi, Mumbai, Pune, Jaipur, Chennai
2024-02-20
Recruiting
Tata Memorial Centre
Observational
1,000
Mumbai
2024-02-15
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Bangalore, Haryāna, Hyderabad, Kolkata, New Delhi, Pune, Thiruvananthapuram
2024-02-05
Recruiting
C K S Teja Institute Of Dental Sciences & Research
Not applicable
30
Tirupati
2024-01-30
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Gūrgaon, Lucknow, Pune
2024-01-22
Recruiting
Queen's University, Belfast
Not applicable
820
Hyderabad
2024-01-18
Recruiting
Colorado Prevention Center
Phase 3
5,200
Guntur, Vijayawada, Patna, Ahmedabad, Kochi, Nagpur, Nashik, New Delhi
2024-01-17
Active, closed
MASLD in Primary Hypothyroidism and Efficacy of Dapaglifozin
NCT06373523Hepatic Steato-Fibrosis, Non-Alcoholic Fatty Liver Disease
DrugDapagliflozin Tab
Post Graduate Institute of Medical Education and Research, Chandigarh
Early Phase 1
50
Chandigarh
2024-01-15
Recruiting
University of Turin, Italy
Observational
10,500
Mumbai
2024-01-15
Recruiting
Translumina Therapeutics Pvt Ltd.
Observational
2,000
Ahmedabad, Bangalore, Bathinda, Chandigarh, Delhi, Gurugram, Hyderabad, Jabalpur
2024-01-10
Active, closed
Pfizer
Phase 2
333
Pune, New Delhi
2024-01-09
Active, closed
Pharmazz, Inc.
Phase 4
160
Guntur, Amravati, Kota, Coimbatore, Jhānsi
2024-01-08
Recruiting
V+PSF-M for Tobacco Cessation in HIV Care in India
NCT05786547Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco
DrugVarenicline
University of Colorado, Denver
Phase 3
400
Chennai
2024-01-02
Recruiting
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Not applicable
150
Lucknow
2024-01-01
Active, closed
Sanofi
Phase 3
943
Bengaluru, Hyderabad, New Delhi, Shimla
2023-12-27
Recruiting
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
NCT06168019Influenza, COVID-19, SARS-COV-2 Infection, Other Respiratory Viruses
Boston University
Observational
10,000
Nagpur
2023-12-26
Active, closed
nthalmic Pty Ltd
Not applicable
210
Surat, Hyderabad
2023-12-22
Active, closed
Bristol-Myers Squibb
Phase 3
190
Ahmedabad, Gurugram, Bengaluru, Pune, New Delhi
2023-12-21
Recruiting
Eli Lilly and Company
Phase 3
1,264
Ahmedabad, Belagavi, Bengaluru, Bhubaneswar, Coimbatore, Hyderabad, Karad, Kolhāpur
2023-12-21
Recruiting
Ascentage Pharma Group Inc.
Phase 3
400
Gandhinagar, Gurugramam, Jhajjar, Bangalore, Mysuru, Navi Mumbai, Pune, Delhi
2023-12-20
Recruiting
AstraZeneca
Phase 3
1,145
Bengaluru, Hyderabad, Jaipur, Kanpur, Kochi, Kolkata, Lucknow, Madurai
2023-12-14
Active, closed
Sanofi
Phase 3
1,655
Chandigarh, Hyderabad, Kochi, Nagpur, Nashik, New Delhi, Shimla, Thiruvananthapuram
2023-12-13
Recruiting
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
NCT05979545Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection, Carbapenem-Resistant Enterobacteriaceae Infection
National University of Singapore
Phase 4
1,526
Vellore
2023-12-12
Recruiting
Predict Tooth Wear
NCT06681844Prediction of Tooth Wear
Hospices Civils de Lyon
Observational
1,000
Lucknow
2023-12-12
Active, closed
Hoffmann-La Roche
Phase 3
1,050
Banglore, Kozhikode, Trivandrum, Mumbai, Pune, Thane
2023-12-11
Active, closed
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
NCT07052006Myelodysplastic Syndrome, Anemia in Myelodysplastic Syndromes
Halia Therapeutics, Inc.
Phase 2
37
Ahmedabad, Kannur, Visakhapatnam, Kolhāpur, Dehradun, Madurai, Hyderabad, Kolkata
2023-12-09
Recruiting
Sir Ganga Ram Hospital
Not applicable
150
New Delhi
2023-12-09
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Bangalore, Mysore
2023-12-07
Active, closed
University College, London
Observational
1,029
Kolkata, Mumbai
2023-12-07
Recruiting
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
330
Pune
2023-12-07
Active, closed
AstraZeneca
Phase 3
760
Delhi, Kolkata, Mumbai, Mysuru, New Delhi, Varanasi
2023-12-04
Recruiting
Chinese University of Hong Kong
Not applicable
81
Chandigarh, Hyderabad, Mumbai, Pune
2023-12-01
Recruiting
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
300
Chandigarh
2023-12-01
Recruiting
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 3
80
Chandigarh
2023-12-01
Recruiting
Akero Therapeutics, Inc
Phase 3
1,650
Surat, Vadodara, Mysore, Thiruvananthapuram, Dahegaon, Mumbai, Nagpur, Pune
2023-12-01
Recruiting
Asian Institute of Gastroenterology, India
Not applicable
158
Hyderabad
2023-11-29
Recruiting
Octapharma
Phase 4
28
Vellore, Bengaluru
2023-11-28
Recruiting
AstraZeneca
Phase 3
625
Calicut, Chennai, Jaipur, Kochi, Kolkata, Kottayam, Marg Jaipur, Mohali
2023-11-23
Active, closed
AstraZeneca
Phase 3
1,898
Bangalore, Calicut, Kanpur, Kolkata, Nagpur, New Delhi, Pune, Vadodara
2023-11-21
Active, closed
Asian Institute of Gastroenterology, India
Not applicable
200
Hyderabad
2023-11-15
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Ahmedabad, Bangalore, Belagavi, Mysore, Nagpur, Nashik, New Delhi, Bikaner
2023-11-15
Active, closed
AstraZeneca
Phase 3
1,902
Bengaluru, Delhi, Kolkata, Marg Jaipur, Nagpur, Nashik, Thiruvananthapuram, Vadodara
2023-11-14
Recruiting
A Study of Chlorophyllin for the Management of Brain Radio-necrosis in Patients With Diffuse Glioma
NCT06016452Diffuse Glioma, Radionecrosis of Brain, High Grade Glioma, Glioblastoma Multiforme
DrugChlorophyllin
Tata Memorial Centre
Phase 2
118
Mumbai
2023-11-13
Active, closed
Akero Therapeutics, Inc
Phase 3
700
Surat, Vadodara, Thiruvananthapuram, Dahegaon, Mumbai, Nagpur, Pune, New Delhi
2023-11-10
Active, closed
AstraZeneca
Phase 3
314
Ahmedabad, Delhi, Gurugram, Hyderabad, Kolkata, Mumbai, Mysuru, New Delhi
2023-11-08
Active, closed
AstraZeneca
Phase 3
1,835
Bangalore, Belagavi, Delhi, Nadiād, New Delhi
2023-11-07
Not yet open
Asian Institute of Gastroenterology, India
Not applicable
200
Hyderabad
2023-11-05
Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
NCT05862012Relapsed/Refractory Multiple Myeloma
Ichnos Sciences SA
Phase 1
200
Gandhinagar, Bangalore, Pune, Hyderabad
2023-11-01
Recruiting
Medanta, The Medicity, India
Not applicable
200
Gurgaon
2023-10-30
Recruiting
Medanta, The Medicity, India
Not applicable
50
Gurgaon
2023-10-30
Active, closed
Novartis Pharmaceuticals
Phase 3
612
Ahmedabad, New Delhi
2023-10-27
Active, closed
Bristol-Myers Squibb
Phase 3
1,057
Ahmedabad, Surat, Belagavi, Bhopal, Nagpur, Pune, New Delhi, Mohali
2023-10-25
Active, closed
Bristol-Myers Squibb
Phase 3
402
Ahmedabad, Bengaluru, New Delhi, Bhubaneswar
2023-10-24
Active, closed
AstraZeneca
Phase 3
895
Bengaluru, Hyderabad, Kolkata, Mysuru, Nagpur, Varanasi
2023-10-24
Recruiting
Aurigene Discovery Technologies Limited
Phase 1
40
Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Srinagar, Belagavi, Kochi
2023-10-19
Recruiting
Predictive Accuracy of PLR and PNR in Detecting ETIC
NCT07046858Trauma Injury, Coagulopathy
Jubilee Mission Medical College and Research Institute
Observational
250
Thrissur
2023-10-17
Recruiting
Medanta, The Medicity, India
Not applicable
100
Gurgaon
2023-10-15
Active, closed
University of California, San Francisco
Not applicable
800
Bangalore
2023-10-12
Active, closed
AstraZeneca
Phase 3
5,511
Ansārinagar, Bangalore, Dehradun, Delhi, Kolkata, Kozhikode, Mumbai, Mysuru
2023-10-05
Recruiting
Novartis Pharmaceuticals
Phase 3
106
Bangalore, Nagpur, Pune, New Delhi, Hyderabad
2023-10-02
Active, closed
All India Institute of Medical Sciences
Not applicable
80
New Delhi
2023-10-01
Not yet open
All India Institute of Medical Sciences
Not applicable
72
New Delhi
2023-10-01
Recruiting
Asian Institute of Gastroenterology, India
Observational
1,000
Hyderabad
2023-10-01
Recruiting
All India Institute of Medical Sciences
Not applicable
60
New Delhi
2023-10-01
Recruiting
Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.
NCT07708987Hematological Malignancy, GVHD - Graft-Versus-Host Disease, Steriod Refractory
Tata Memorial Centre
Phase 2
34
Navi Mumbai
2023-09-23
Recruiting
AstraZeneca
Phase 3
800
Calicut, Jaipur, Lucknow, Madurai, Mohali, Nagpur, Nashik, New Delhi
2023-09-22
Active, closed
Bristol-Myers Squibb
Phase 3
1,255
Ahmedabad, Surat, Belagavi, Bhopal, Nagpur, Pune, New Delhi, Mohali
2023-09-14
Recruiting
Tata Memorial Centre
Observational
6,000
Mumbai
2023-09-13
Recruiting
Hoffmann-La Roche
Phase 3
230
Ahmedabad, Surat, Gurugram, Mumbai, Nagpur, NEW Delhi Delhi, Kolkata
2023-09-08
Recruiting
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
NCT05514340Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy
DrugSovateltide
Pharmazz, Inc.
Phase 2
40
Mangalore, Ludhiana, Hyderabad, Kanpur
2023-09-06
Recruiting
Aurigene Discovery Technologies Limited
Phase 1
50
Vijayawada, Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Bangalore, Mysore
2023-09-05
Recruiting
Comorbidities Resolution After MGB Surgery and Change in Body Composition
NCT06015620Morbid Obesity, Type2diabetes, Sleep Apnea, Hypothyroidism
All India Institute of Medical Sciences, Bhubaneswar
Observational
35
Bhubaneswar
2023-09-01
Recruiting
M.D. Anderson Cancer Center
Not applicable
60
Giddenahalli
2023-08-28
Recruiting
Tata Memorial Centre
Phase 2
18
Navi Mumbai
2023-08-28
Recruiting
Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.
NCT07400809Chemotherapy, Treatment Compliance, Radiotherapy, Cervix Cancer
Tata Memorial Hospital
Observational
350
Mumbai
2023-08-23
Recruiting
Character-Strengths Based Coaching For Work-Stress Reduction For Health Workers
NCT06013488Work Related Stress, Burnout, Psychological, Mental Health Issue
Templeton World Charity Foundation
Not applicable
330
Bhopal
2023-08-21
Recruiting
Onabotulinum Toxin A (Botox) in the Treatment of Pharyngo-esophageal Dysphagia
NCT04695600Transfer Dysphagia, Oropharyngeal Dysphagia, Cricopharyngeus Muscle Dysfunction
DrugsBotulinum toxin type A·Botox
All India Institute of Medical Sciences
Phase 2/3
100
New Delhi
2023-08-11
Active, closed
nthalmic Pty Ltd
Not applicable
441
Hyderabad
2023-08-04
Recruiting
University Hospital, Basel, Switzerland
Not applicable
70
Chennai, Hyderabad
2023-08-01
Recruiting
GlaxoSmithKline
Phase 3
892
Bengaluru, Ludhiana, Belagavi, Hyderabad, Nashik, Pune
2023-08-01
Recruiting
Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
NCT07062263Biliary Tract Cancer, HER2-positive Cancer, Advanced Cancer, Unresectable Biliary Tract Carcinoma
DrugTrastuzumab
Tata Memorial Centre
Phase 3
220
Muzaffarpur, Mumbai, Bhubaneswar, Mūllānpur, Varanasi, Delhi
2023-07-21
Active, closed
The Aurum Institute NPC
Phase 4
1,000
Pune
2023-07-19
Recruiting
Cardiac Dysfunction in Patients with Fatty Liver Disease
NCT06386094NAFLD, Cardiac Disease, Fatty Liver, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
150
Chandigarh
2023-07-15
By invitation
A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection
NCT05921162Retinitis Pigmentosa, Retinal Disease, Retinal Degeneration
Nanoscope Therapeutics Inc.
Observational
11
Cuttack
2023-07-14
Active, closed
Minoryx Therapeutics, S.L.
Phase 3
40
New Delhi
2023-07-12
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Nagpur, Chandigarh, Ajmer, Hyderabad, Kolkata, Varanasi
2023-07-11
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Hyderabad, Chandigarh, Faridabad, Bengaluru, Trivandrum, Jaipur, Vellore, Lucknow
2023-07-06
Active, closed
Tata Memorial Centre
Phase 2
76
Mumbai, Navi Mumbai
2023-07-05
Recruiting
P+F Products + Features GmbH
Not applicable
267
Bangalore, Gūrgaon, Jaipur, Kochi, Vellore
2023-07-03
Recruiting
Postgraduate Institute of Dental Sciences Rohtak
Not applicable
24
Rohtak
2023-07-01
Recruiting
All India Institute of Medical Sciences, Bhubaneswar
Not applicable
108
Bhubaneswar
2023-07-01
Recruiting
Friedreich's Ataxia Research Alliance
Observational
3,000
New Delhi
2023-06-28
Active, closed
Hoffmann-La Roche
Phase 3
2,000
Hyderabad, Ahmedabad, Faridabad, Hubli, Nagpur, Pune, Ajmer, Jaipur
2023-06-28
Active, closed
Viatris Innovation GmbH
Phase 3
451
Ahmedabad, Chennai, Hyderabad, Kolkata, Nagpur, Nashik, New Delhi, Pune
2023-06-26
Active, closed
Alumis Inc
Phase 2
408
New Delhi, Ahmedabad, Bangalore, Bengaluru, Chandigarh, Haryāna, Jaipur, Lucknow
2023-06-26
Active, closed
Population Health Research Institute
Not applicable
5,100
Ernākulam, Kollam, Kottayam, Indore, Jaipur, Chennai, Madurai, Gurugramam
2023-06-22
Recruiting
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
NCT05427370Coronary Artery Disease, Heart Failure Systolic
Sunnybrook Health Sciences Centre
Not applicable
754
Palayam
2023-06-22
Active, closed
Bristol-Myers Squibb
Phase 3
1,230
Chandigarh, Bangalore, Kochi, Kolhāpur, Nagpur, Pune, Bhubaneswar, Kolkata
2023-06-22
Recruiting
Forma Therapeutics, Inc.
Phase 2
27
Raipur, Delhi, Gujarat, Maharashtra, Nagpur
2023-06-20
Active, closed
Eli Lilly and Company
Phase 3
3,127
Guntur, Bangalore, Mysore, Nagpur, Pune
2023-06-05
Active, closed
Bristol-Myers Squibb
Phase 4
85
Ahmedabad, New Delhi, Kolkata, Assam, Bangalore, Chandigarh, Delhi, Hyderabad
2023-06-05
Recruiting
Myra Vision Inc.
Not applicable
60
Chennai
2023-05-31
Recruiting
Tata Memorial Centre
Not applicable
90
Navi Mumbai, Mumbai
2023-05-29
Recruiting
Pfizer
Phase 3
318
Gurugram (Gurgaon), Kochi, Kolkata
2023-05-20
Recruiting
Intra-Cellular Therapies, Inc.
Phase 3
470
Ahmedabad, Ajmer, Bārāmati, Bikaner, Chandigarh, Guwahati, Kolhāpur, Nagpur
2023-05-02
Active, closed
Australian and New Zealand Intensive Care Research Centre
Phase 3
500
Puducherry, Ludhiana
2023-04-26
Recruiting
Yoga Based Cardiac Rehabilitation in Heart Failure Failure
NCT07817589Heart Failure With Reduced Ejection Fraction, Heart Failure NYHA Class II, Heart Failure NYHA Class III
Centre for Chronic Disease Control, India
Not applicable
3,500
Dharwad, Mysore, Shillong, New Delhi, Ludhiana, Jodhpur, Chennai, Rishikesh
2023-04-24
Active, closed
Novartis Pharmaceuticals
Phase 3
288
Ahmedabad, Kozhikode, Kolhāpur, Nagpur, Nashik, Pune, New Delhi, Dehradun
2023-04-21
Active, closed
AstraZeneca
Observational
712
Gurugram, New Delhi, Hyderabad, Bangalore, Chennai, Kolkata, Mumbai, Pune
2023-04-20
Recruiting
Zydus Lifesciences Limited
Phase 4
1,004
Sheikhpura
2023-04-20
Recruiting
Pfizer
Phase 2
48
Bangalore, Lucknow, Kolkata
2023-04-18
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Coimbatore, Hyderabad
2023-04-17
Active, closed
TrEatment Approach in the Multimodal Era Registry
NCT05629052Chronic Thromboembolic Pulmonary Hypertension, CTEPH
International CTEPH Association
Observational
1,000
Bangalore
2023-04-12
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Aligarh, Amritsar, Bangalore, Belagavi, Bengaluru, Bikaner, Chennai, Chhatrapati Sambhajinagar
2023-04-11
Active, closed
Sanofi
Phase 2
999
Bengaluru, Bikaner, Kochi, Kolkata, Mangaluru, Nashik, Surat
2023-04-03
Recruiting
AstraZeneca
Phase 3
4,300
Bangalore, Belagavi, Bhubaneswar, Hubli, Hyderabad, Jaipur, Kolkata, Mumbai
2023-03-31
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Gūrgaon, Jaipur, Pune
2023-03-29
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Bangalore, Chandigarh, Gurugram, Kolkata, Mumbai, Pune
2023-03-23
Recruiting
Vega Therapeutics, Inc
Phase 1/2
116
Sion
2023-03-16
Recruiting
BPH Global Registry
NCT05543200Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Société Internationale d'Urologie
Observational
7,500
Delhi
2023-03-13
Recruiting
Cerium Pharmaceuticals, Inc.
Phase 3
148
Guntur, Nellore, Raipur, Nadiād, Belagavi, Nagpur, New Delhi, Chandigarh
2023-03-13
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Guntur, Ahmedabad, Bangalore, Belagavi, Mangalore, Manipal, Mysore, Kochi
2023-03-09
Recruiting
Regeneron Pharmaceuticals
Phase 3
202
Kochi, Mumbai, New Delhi, Chandigarh, Jaipur
2023-03-07
Active, closed
Pfizer
Phase 3
624
Gurgaon, Mumbai, Nashik, Thane, New Delhi, Kolkata
2023-03-03
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Guntur, Hyderabad, Vijayawada, Guwahati, Raipur, Ahmedabad, Surat, Vadodara
2023-03-01
Active, closed
Janssen Research & Development, LLC
Phase 3
12,523
Ahmedabad, Ajmer, Anand, Bangalore, Belagavi, Bhubaneswar, Bikaner, Chennai
2023-02-15
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Surat, Mumbai, Pune, Ludhiana, Jaipur, Ranipet, Noida
2023-02-13
Active, closed
Asian Institute of Gastroenterology, India
Not applicable
96
Hyderabad
2023-02-10
Active, closed
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
NCT05605535Ovarian Neoplasm Epithelial, Ovarian Cancer, Fallopian Tube Neoplasms, Peritoneal Carcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 2
88
Visakhapatnam, Vadodara, Belagavi, Kochi, Trivandrum, Puducherry, Jaipur, Chennai
2023-02-07
Active, closed
Novartis Pharmaceuticals
Phase 3
226
Ahmedabad, Rishikesh
2023-02-03
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Rishikesh, Kolkata
2023-02-02
Recruiting
Immune Oncology Research Institute
Observational
300
New Delhi
2023-02-01
Active, closed
Sanofi
Phase 3
91
Bangalore, Bhubaneswar, Pune-411011, Punjab, Vellore
2023-02-01
Recruiting
Johns Hopkins University
Phase 3
4,874
Hyderabad, Kolkata, Chandigarh
2023-01-18
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Hyderabad, Secunderabad, Ahmedabad, Rajkot, Surat, Vadodara, Gurgaon, Bangalore
2023-01-16
Active, closed
Bristol-Myers Squibb
Phase 3
516
Vizianagaram, Ahmedabad, Surat, Gurugram, Bengaluru, Hyderabad
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
513
Ahmedabad, Hubli, Mysore, Nagpur, Vellore, Hyderabad, Secundarabad
2023-01-12
Active, closed
Bristol-Myers Squibb
Phase 3
606
Gurgaon, Bengaluru, Mumbai, Thane, New Delhi, Mohali, Chennai, Hyderabad
2023-01-10
Active, closed
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease
DrugGSK4532990
GlaxoSmithKline
Phase 2
284
Bhubaneswar, Chandigarh, Coimbatore, Guhawati, Mumbai, Nagpur, New Delhi, Secunderabad
2023-01-02
Recruiting
Erythropoietin for Neonatal Encephalopathy in LMIC (EMBRACE Trial)
NCT05395195Encephalopathy, Erythropoietin, Newborn Asphyxia
DrugErythropoietin
Imperial College London
Phase 3
504
Bangalore, Chennai, Chhatrapati Sambhajinagar, Hubli, Mumbai
2022-12-31
Active, closed
Novartis Pharmaceuticals
Phase 3
90
New Delhi, Madurai, Hyderabad, Lucknow
2022-12-30
Active, closed
AstraZeneca
Phase 3
1,350
Calicut, Delhi, Jaipur, Kolkata, Madurai, Puducherry
2022-12-29
By invitation
Tolmar Inc.
Phase 3
250
Surat, Bangalore, Bengaluru, Mysore, Nagpur, Pune, Erode, Varanasi
2022-12-28
Recruiting
Anthos Therapeutics, Inc.
Phase 3
2,500
Hyderabad, Kochi, Rudrapur, Ahmedabad, Ajmer, Bangalore, Bhubaneswar, Chandigarh
2022-12-27
Recruiting
AstraZeneca
Phase 3
3,527
Ahmedabad, Belagavi, Chennai, Dehradun, Gurugram, Gūrgaon, Hyderabad, Kanpur
2022-12-13
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 3
885
Mangalore, New Delhi
2022-12-13
Active, closed
Viatris Innovation GmbH
Phase 3
470
Ahmedabad, Bangalore, Chennai, Hyderabad, Jaipur, Nagpur, Nashik, Pune
2022-12-13
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Belagavi
2022-12-09
Recruiting
Pfizer
Phase 3
100
Surat, Mumbai, Kolkata
2022-12-09
Recruiting
Bile Acids Metabolism and Genetic Mutation Profile in the Intrahepatic Cholestasis of Pregnacy in Indian Population
NCT05691036Intrahepatic Cholestasis of Pregnancy, Genetic Mutation, Health Related Quality of Life
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
150
Chandigarh
2022-12-08
Active, closed
Celcuity Inc
Phase 3
701
Jaipur, Bangalore, Chandigarh, Kolkata, Navi Mumbai, Vellore
2022-12-08
Active, closed
Novartis Pharmaceuticals
Phase 2
95
Thellakom Kottayam, Varanasi
2022-12-06
Active, closed
Bellus Health Inc. - a GSK company
Phase 3
997
Belagavi, Faridabad, Nagpur, Nashik, Visakhapatnam
2022-12-05
Recruiting
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
NCT05512169ALL, Childhood, Pediatric Cancer, Toxicity, Drug, Adverse Drug Event
University of Geneva, Switzerland
Observational
556
New Delhi, Puducherry
2022-12-01
Active, closed
Sanofi
Phase 2
187
Gūrgaon, Jaipur, Kochi, Ludhiana, New Delhi, Pune, Rajkot, Secunderabad
2022-11-25
Active, closed
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
144
Chandigarh, Hyderabad, Jaipur, Jodhpur, Lucknow, New Delhi, Rishikesh, Vellore
2022-11-23
Active, closed
Novartis Pharmaceuticals
Phase 3
568
Ahmedabad, New Delhi, Chennai, Varanasi, Rishikesh
2022-11-21
Recruiting
Bayer
Phase 3
100
Ahmedabad, Bengaluru, Delhi, Kolkata
2022-11-08
Recruiting
NAOS Argentina S.A.
Not applicable
100
New Delhi
2022-11-03
Recruiting
Shire
Phase 4
5
Kolkata, New Delhi
2022-11-01
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Surat, Belagavi, Kozhikode, Mumbai, Nagpur, Pune, Delhi, Chandigarh
2022-11-01
Recruiting
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
NCT05929976Acute Lymphoblastic Leukemia, Nutrition Aspect of Cancer, Microtia, Genetic Predisposition
Columbia University
Observational
4,900
Chandigarh
2022-10-26
Active, closed
Nemours Children's Clinic
Not applicable
3,442
Belagavi, Nagpur, Pune, Chandrapur, Wardha, Jaipur
2022-10-17
Active, closed
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries
NCT03657394Hypoxic-Ischemic Encephalopathy, Birth Asphyxia
Nemours Children's Clinic
Not applicable
3,442
Belagavi, Nagpur, Pune, Chandrapur, Wardha, Jaipur
2022-10-17
Active, closed
Eli Lilly and Company
Phase 3
15,374
Ahmedabad, Bikaner, Hyderabad, Lucknow, Ludhiana, Mumbai, Nagpur, New Delhi
2022-10-11
Active, closed
Eli Lilly and Company
Phase 3
8,000
Ahmedabad, Bangalore, Belagavi, Bhubaneswar, Chandigarh, Chennai, Hyderabad, Kanpur
2022-10-04
Recruiting
NATCO Pharma Ltd.
Phase 2
21
Mumbai, Pune, Hyderabad
2022-09-30
Recruiting
Pfizer
Phase 2/3
389
Raipur, Surat, Vadodara, Nashik, New Delhi, Bhubaneswar
2022-09-22
Active, closed
Johns Hopkins University
Not applicable
450
Pune
2022-09-22
Recruiting
Celgene
Phase 3
810
Ahmedabad, Gurugram, Belagavi, Mumbai, Madurai, Varanasi, Ludhiana, Puducherry
2022-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
577
Bangalore, Bhubaneswar, Jaipur, New Delhi, Secunderabad, Surat
2022-09-19
Active, closed
AstraZeneca
Phase 3
594
Jaipur, Pune, Surat
2022-09-15
Recruiting
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NCT05325034Cardiovascular Diseases, Acute Coronary Syndrome, Atherosclerosis, Hypercholesterolemia
Stephen Nicholls
Not applicable
2,000
New Delhi
2022-09-15
Active, closed
YoUng Adolescents' behaViour, musculoskeletAl heAlth, Growth & Nutrition
NCT05603793Arrest of Bone Development or Growth, Constitutional Delay of Growth and Puberty, Malnutrition, Child, Gestational Diabetes
Hirabai Cowasji Jehangir Medical Research Institute
Observational
1,304
Pune
2022-09-13
Active, closed
Janssen Research & Development, LLC
Phase 3
418
Gurugram, Hyderabad, Manipal, Mumbai, Surat
2022-09-13
Recruiting
Christian Medical College and Hospital, Ludhiana, India
Phase 4
3,400
Guntur, Dibrugarh, Guwahati, Tezpur, Panjim, Anand, Gurgaon, Bilāspur
2022-08-30
Recruiting
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
410
Ahmedabad, New Delhi, Hyderabad
2022-08-23
Active, closed
Sanofi
Phase 2/3
1,856
Ahmedabad, Belagavi, Chandigarh, Kolkata, Nagpur, Pune
2022-08-22
Recruiting
Post Graduate Institute of Medical Education and Research, Chandigarh
Observational
100
Chandigarh
2022-08-15
Recruiting
Intech Biopharm Ltd.
Not applicable
148
Ahmedabad, Belagāve, Kolkata, New Delhi, Pune, Ulhasnagar
2022-08-15
Recruiting
International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery
NCT05673499Congenital Disorders, Cerebral Desaturation, Neonatal Surgery
Children's Hospital of Philadelphia
Observational
900
Chandigarh, Vellore
2022-08-12
Active, closed
Novo Nordisk A/S
Phase 3
412
Kochi, Pune, New Dehli
2022-08-10
Active, closed
Novartis Pharmaceuticals
Phase 3
506
Ahmedabad, Bangalore, Pune, New Delhi
2022-08-04
Recruiting
Bayer
Phase 4
50
Nadiād, Bengaluru, Kochi, Thiruvananthapuram, Vellalasseri, Amravati, Mumbai, New Delhi
2022-08-03
Active, closed
Biocad
Phase 3
270
Faridabad, Mangalore, Mumbai, Nagpur, Nashik, New Delhi, Pune, Sangli
2022-08-02
Recruiting
CHA University
Not applicable
240
Bengaluru
2022-08-01
Recruiting
PRISMA Maternal and Newborn Health Study
NCT05904145Pregnancy, High Risk
George Washington University
Observational
267,897
Vellore
2022-08-01
Active, closed
Regeneron Pharmaceuticals
Phase 3
202
Kannur, Kochi, Mumbai, New Delhi, Chandigarh, Lucknow, Jaipur
2022-08-01
Active, closed
PureTech
Phase 2
240
Vadodara, Bengaluru, Chhatrapati Sambhajinagar, Nagpur, Hyderabad, Kanpur, Kolkata, Belagāve
2022-07-22
Active, closed
Janssen Research & Development, LLC
Phase 2
703
Ahmedabad, Bengaluru, Bhubaneswar, Chennai, Gūrgaon, Hyderabad, Mumbai, New Delhi
2022-07-22
Active, closed
Hoffmann-La Roche
Phase 3
922
Bangalore, Mumbai, Pune, New Delhi, Kolkata
2022-07-18
Active, closed
Tata Memorial Centre
Not applicable
200
Mumbai
2022-07-15
Active, closed
Novartis Pharmaceuticals
Phase 3
452
Bangalore, Secunderabad, Lucknow, Chandigarh
2022-07-14
Active, closed
Novartis Pharmaceuticals
Phase 3
610
Bangalore, New Delhi, Chennai, Coimbatore, Lucknow, Dehradun
2022-07-08
Active, closed
Novartis Pharmaceuticals
Phase 4
134
Bhubaneswar, Delhi
2022-07-07
Recruiting
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
NCT05430971Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Immune Oncology Research Institute
Observational
200
New Delhi
2022-07-01
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
Chandigarh, Ahmedabad, Bangalore, Bhubaneswar, Bikaner, Noida
2022-06-30
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
529
Surat, Belagavi, Hubli, Pune, Bangalore, Chennai, Secunderabad, Sevilla
2022-06-30
Active, closed
Glenmark Specialty S.A.
Phase 1
320
Vijayawada, Visakhapatnam, Gurgaon, Bangalore, Bengaluru, Kannur, Chhatrapati Sambhajinagar, Mumbai
2022-06-28
Active, closed
Celgene
Phase 3
939
Hyderabad, Bangalore, Ernākulam, Mumbai, Kolkata, Puducherry
2022-06-23
Active, closed
Novartis Pharmaceuticals
Phase 3
95
Jaipur, Delhi
2022-06-15
Recruiting
Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
NCT05444946Chronic Pulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis
DrugItraconazole
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
104
Chandigarh
2022-06-15
Active, closed
Tata Memorial Hospital
Phase 1
12
Mumbai
2022-06-08
Active, closed
Hoffmann-La Roche
Phase 3
188
Bangalore North
2022-05-19
Active, closed
Istituto Giannina Gaslini
Observational
272
Mumbai
2022-05-18
Active, closed
AstraZeneca
Phase 3
644
Bangalore, Jaipur, Kolkata, Nagpur, Nashik, New Delhi, Puducherry, Vadodara
2022-05-16
Recruiting
Transcriptomic Responses for the Identification of Pathogens
NCT04878549Enteric Fever, Acute Febrile Illness, Typhoid, Paratyphoid Fever
University of Sheffield
Observational
2,000
Vellore
2022-05-02
Not yet open
University of Zurich
Not applicable
40
Pune
2022-05
Recruiting
Sir Ganga Ram Hospital
Phase 4
46
New Delhi
2022-04-19
By invitation
AstraZeneca
Phase 3
214
Chennai
2022-04-19
Active, closed
AO Innovation Translation Center
Observational
1,000
Mangalore
2022-04-05
By invitation
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 2/3
600
Hyderabad, Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Pune
2022-04-05
Active, closed
AstraZeneca
Phase 3
760
Ahmedabad, Bangalore, Delhi, Hyderabad, Jaipur, Kolkata, Mumbai, New Delhi
2022-03-28
Active, closed
Bayer
Phase 3
219
Ahmedabad, Bengaluru, Delhi, Kolkata
2022-03-28
Active, closed
Pfizer
Phase 3
854
Gurugram, Dehradun, Kolkata, Delhi
2022-03-25
Active, closed
AstraZeneca
Phase 3
1,035
Bikaner, Meerut, Mohali, New Delhi
2022-03-25
Active, closed
Novo Nordisk A/S
Phase 3
153
Guwahati, Surat, Kolhāpur, Mumbai, Pune, Cuttack, Jaipur, Noida
2022-03-24
Active, closed
COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular Events
NCT05333068Multivessel Coronary Artery Disease, Ischemia, Vulnerable Plaque, Coronary Artery Disease
Diagram B.V.
Not applicable
1,223
Ahmedabad, Bangalore, Chandigarh
2022-03-16
Active, closed
Otsuka Pharmaceutical Development & Commercialization, Inc.
Phase 3
530
Ahmedabad, Nadiād, Bengaluru, Manipal, Kozhikode, Thiruvananthapuram, Chhatrapati Sambhajinagar, Pune
2022-03-15
Active, closed
Genentech, Inc.
Phase 4
218
Hubli, Pune, Ahmedabad, Chennai, Madurai, Kolkata, Chandigarh
2022-02-28
Recruiting
Tata Memorial Hospital
Observational
1,800
Navi Mumbai
2022-02-24
Recruiting
Institute of Liver and Biliary Sciences, India
Not applicable
200
New Delhi
2022-02-23
By invitation
University of North Carolina, Chapel Hill
Not applicable
20,160
Darjeeling
2022-02-20
Active, closed
AstraZeneca
Phase 3
791
Ahmedabad, Bangalore, Delhi, Howrah, Hyderabad, Jaipur, Kolkata, Marg Jaipur
2022-02-18
Active, closed
AstraZeneca
Phase 3
363
Ahmedabad, Dehradun, Delhi, Hyderabad, Kolkata, Nadiād, Pune, Secunderabad
2022-02-15
Recruiting
Acetazolamide for Treatment Resistant Schizophrenia
NCT04887792Schizophrenia, Schizo Affective Disorder
DrugAcetazolamide
Vishwajit Nimgaonkar, MD PhD
Phase 1/2
60
Bangalore
2022-02-01
Active, closed
Immunic AG
Phase 3
1,100
Chandigarh, Haryāna, Lucknow, New Delhi, Punjābi Bāgh, Raipur
2022-01-12
Recruiting
Xingshun Qi
Observational
3,000
Kochi
2022-01-01
Recruiting
World Health Organization
Not applicable
12,612
Jaipur
2022-01-01
Active, closed
Lorlatinib Continuation Study
NCT05144997Non-Small-Cell Lung Cancer, NSCLC
DrugLorlatinib
Pfizer
Phase 4
76
Bengaluru, Thane
2021-12-28
Active, closed
ITM Solucin GmbH
Phase 3
259
Bangalore, New Delhi, Mumbai
2021-12-21
Active, closed
Eli Lilly and Company
Phase 3
152
Thiruvananthapuram, Mumbai, Nagpur, Nashik, New Delhi
2021-12-20
Active, closed
Sanofi
Phase 4
1,339
Ahmedabad, Chandigarh, Coimbatore, Jaipur, Jodhpur, Kozhikode, Lucknow, Mangaluru
2021-12-16
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Mangalore, Mumbai, Nashik, New Delhi, Chandigarh, Ludhiana, Lucknow, Dehradun
2021-12-16
Active, closed
GlaxoSmithKline
Phase 2
366
Belagavi, Coimbatore, Hyderabad, Kanchan Bagh Hyderabad, Mumbai, New Delhi, Pune, Surat
2021-12-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Guntur, Surat, Panjagutta, Udupi, Kochi, Pune, Parel, New Delhi
2021-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Kochi, Pune, New Delhi, Amritsar, Hyderabad, Lucknow, Kolkata
2021-12-13
Recruiting
Johnson & Johnson Enterprise Innovation Inc.
Phase 3
500
Bangalore, Chennai, Madurai, Mumbai, Nashik, New Delhi, Pune, Vijayawada
2021-12-10
Active, closed
Jazz Pharmaceuticals
Phase 3
920
Bhubaneswar, Gūrgaon, Hyderabad, New Delhi, Patna, Vijayawada
2021-12-02
Not yet open
Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial
NCT05144100Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
Tata Memorial Centre
Phase 2/3
498
Mumbai
2021-12-01
Recruiting
Tata Memorial Centre
Not applicable
74
Mumbai, Navi Mumbai
2021-12-01
Active, closed
Novartis Pharmaceuticals
Phase 3
17,004
Guntur, Hyderabad, Ahmedabad, Vadodara, Belagavi, Manipal, Mysore, Kochi
2021-11-23
Recruiting
Biotech Healthcare Holding Gmbh
Not applicable
138
Bangalore, Chennai
2021-11-22
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Bangalore, Alappuzha, Trivandrum, New Delhi, Puducherry
2021-11-22
Active, closed
Immunic AG
Phase 3
1,121
Bangalore, Mangalore, Nagpur, New Delhi, Pune, Shimla, Varanasi
2021-11-18
Recruiting
Pfizer
Phase 3
245
Surat, Mumbai, Pune, Kolkata
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Bangalore, Gurugram, Kolkata, Mumbai, Nashik, New Delhi, Pune, Thane
2021-11-17
Active, closed
Hoffmann-La Roche
Phase 3
41
Ahmedabad, Gurgaon, New Delhi
2021-11-17
Active, closed
Novartis Pharmaceuticals
Phase 3
153
Hisar, New Delhi, Chennai
2021-11-15
Recruiting
Dr.Pankaj Chaturvedi
Not applicable
1,206
Mumbai, Navi Mumbai, Varanasi
2021-11-15
Recruiting
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
NCT04754022Disorder, Heart, Postoperative, Cardiac Surgery
Unity Health Toronto
Not applicable
1,440
Ahmedabad
2021-11-01
Recruiting
Tata Memorial Hospital
Observational
200
Mumbai
2021-10-30
Active, closed
AstraZeneca
Phase 3
148
Bangalore, Belagavi, Jaipur, Mysore, Nashik
2021-10-28
Active, closed
AstraZeneca
Phase 3
454
Bangalore, Delhi, Hyderabad, Mumbai, Nashik
2021-10-28
Active, closed
AstraZeneca
Phase 3
927
Gūrgaon, Howrah, Nagpur, Nashik, New Delhi, Raipur, Rishikesh, Surat
2021-10-25
Active, closed
Hoffmann-La Roche
Phase 3
83
New Delhi
2021-10-22
Active, closed
AstraZeneca
Phase 3
732
Gūrgaon, Howrah, Hyderabad, Jaipur, Kolkata, Nashik, Surat, Visakhapatnam
2021-10-18
Active, closed
Beeline Medicines Corporation
Phase 2
248
Ahmedabad, Gurugram, Bengaluru, New Delhi, Secunderabad
2021-10-11
Recruiting
A Prospective, Randomized Clinical Study of Two Phakic Toric Implantable Lenses
NCT06839898Myopia, Moderate, Myopic Astigmatism, Myopia, Degenerative
Biotech Healthcare Holding Gmbh
Not applicable
172
Bangalore
2021-10-10
Active, closed
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
NCT04971226Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
DrugsBosutinib·Asciminib·ABL001·Nilotinib
Novartis Pharmaceuticals
Phase 3
405
Delhi
2021-10-06
Active, closed
Novartis Pharmaceuticals
Phase 3
129
New Delhi, Lucknow, Kolkata
2021-10-05
Active, closed
Eli Lilly and Company
Phase 3
874
Bangalore, Thiruvananthapuram, Mumbai, Nagpur, Nashik, Pune, Hyderabad
2021-10-04
Recruiting
Tata Memorial Centre
Observational
720
Mumbai
2021-10-04
Active, closed
Hoffmann-La Roche
Phase 3
217
Kozhikode, Mumbai, New Delhi, Varanasi, Kolkata
2021-09-30
Active, closed
PolyNovo Biomaterials Pty Ltd.
Not applicable
150
Chhatrapati Sambhajinagar, Mumbai, Coimbatore
2021-09-21
Recruiting
Novartis Pharmaceuticals
Phase 3
540
Bangalore, New Delhi, Hyderabad
2021-09-20
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Vijayawada, Patna, Ahmedabad, Surat, Vadodara, Belagavi, Amravati, Kolhāpur
2021-08-27
By invitation
Viatris Innovation GmbH
Phase 3
25,000
Ahmedabad, Aligarh, Bangalore, Bathinda, Belagavi, Bhubaneswar, Bikaner, Chennai
2021-08-14
Recruiting
Pharmazz, Inc.
Phase 4
400
Nellore, Raipur, Vadodara, Nagpur, Amritsar, Ludhiana, Kota, Coimbatore
2021-08-13
Recruiting
Novartis Pharmaceuticals
Phase 3
98
New Delhi, Hyderabad, Lucknow, Dehradun
2021-07-28
Recruiting
Meyer Children's Hospital IRCCS
Observational
103
Bangalore, Chandigarh, Chennai, Kochi, Kolkata
2021-07-13
Recruiting
All India Institute of Medical Sciences
Phase 3
136
Jhajjar
2021-07-12
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Bengaluru, Mumbai, New Delhi, Jaipur, Chennai, Gurugramam, Kochi, Secunderabad
2021-07-08
Active, closed
Tolmar Inc.
Phase 3
250
Vijayawada, Visakhapatnam, Ahmedabad, Surat, Bengaluru, Mysore, Nagpur, Nashik
2021-07-01
Active, closed
National Institute of Allergy and Infectious Diseases (NIAID)
Observational
1,500
Chennai
2021-06-01
Active, closed
D9319C00001- 1L OC Mono Global RCT
NCT04884360Ovarian Cancer
DrugOlaparib
AstraZeneca
Phase 3
366
Gūrgaon, Jaipur, Kolkata, Madurai, Namakkal, Nashik, New Delhi
2021-05-31
Active, closed
Pfizer
Phase 3
599
Surat, Gurugram, Mumbai, Pune, New Delhi, Meerut, Kolkata
2021-05-12
Active, closed
AstraZeneca
Phase 3
893
Bangalore, Mohali, Mysuru, Nagpur, New Delhi, Vadodara, Varanasi
2021-05-10
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Ahmedabad, Bangalore, Mumbai, Nashik, Pune, New Delhi, North WEST Delhi, Ratnagiri Kilminnal
2021-05-04
Recruiting
Efficacy of Hyperthermic Intraperitoneal Chemotherapy
NCT04861558Colorectal Cancer, Peritoneal Metastases
Drugs5Fluorouracil·Irinotecan·Oxaliplatin
Uppsala University
Phase 3
213
Ahmedabad
2021-05-01
Active, closed
AstraZeneca
Phase 3
1,157
Ahmedabad, Bangalore, Bengaluru, Calicut, Gūrgaon, Mysuru, Nashik, New Delhi
2021-04-26
Recruiting
University of California, San Francisco
Not applicable
26,436
Vellore
2021-04-14
Active, closed
Geron Corporation
Phase 3
327
Surat, Bangalore, Bengaluru, New Delhi, Gūrgaon, Bhubaneswar, Kolkata, Pune
2021-04-12
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Secunderabad, Surat, Gurgaon, Mangalore, Mumbai, Nagpur, Delhi, Ghitorni
2021-04-01
Recruiting
Post Graduate Institute of Medical Education and Research, Chandigarh
Not applicable
1,018
Chandigarh
2021-03-30
Active, closed
Hoffmann-La Roche
Phase 3
751
Ahmedabad, Mumbai, Pune, New Delhi, Ludhiana, Vadapalani, Chandigarh
2021-03-24
Active, closed
Novo Nordisk A/S
Phase 3
78
Guntur, New Delhi
2021-03-04
Recruiting
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.
NCT04766866Preeclampsia, Intrauterine Growth Restriction, Maternal Hypertension, Neonatal Outcome
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Not applicable
9,132
New Delhi
2021-03-02
Active, closed
Sellas Life Sciences Group
Phase 3
127
Kannur, Hyderabad, Ludhiāna, New Delhi, Patna
2021-02-08
Recruiting
Tata Memorial Hospital
Observational
618
Mumbai
2021-02-01
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
Mumbai, Hyderabad, Bangalore, Cutack, New Delhi
2021-01-29
Active, closed
AstraZeneca
Phase 3
1,371
Ahmedabad, Calicut, Delhi, Faridabad, Gūrgaon, Karamsad, Kolkata, Madurai
2021-01-28
Recruiting
Sir Ganga Ram Hospital
Observational
270
New Delhi
2021-01-14
Active, closed
AstraZeneca
Phase 1/2
245
Delhi, Gūrgaon, Madurai, Mumbai
2020-12-28
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Surat, Bangalore, Mumbai, Nashik, New Delhi, Hyderabad
2020-12-22
Active, closed
Pfizer
Phase 3
841
Mumbai, Pune, Thane, New Delhi, Jaipur
2020-12-21
Active, closed
AstraZeneca
Phase 3
358
Mumbai, Namakkal, New Delhi, Varanasi
2020-12-16
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Kozhikode, Pune, Vellore, Hyderabad, Secunderabad, Kolkata
2020-12-11
Active, closed
Janssen Research & Development, LLC
Phase 3
518
Amravati, Bangalore, Bikaner, Nashik, New Delhi, Patna, Pune
2020-12-07
Active, closed
Amgen
Phase 3
135
Bangalore
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Ahemdabad, Ahmedabad, Bangalore, Belagavi, Chhatrapati Sambhajinagar, Howrah, Hyderabad, Jaipur
2020-12-02
Active, closed
Eli Lilly and Company
Phase 3
312
Ahmedabad, Gurugram, Kanpur, Mangalore, Nagpur, New Delhi, Pune
2020-11-25
Recruiting
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
NCT04256798Infection, Pneumonia, Surgical Site Infection, Wound Infection
DrugChlorhexidine mouthwash
University of Birmingham
Phase 3
12,942
Visakhapatnam, Srinagar, Chinchpāda, Madhava Nagar, Patiāla, Bhubaneswar, Chandigarh, Jodhpur
2020-11-13
Recruiting
Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT
NCT05236946Asymptomatic Brain Metastases, Driver Mutation Positive Non-small Cell Lung Cancer
Tata Memorial Hospital
Phase 3
190
Mumbai
2020-11-10
By invitation
University of Zurich
Not applicable
26
Pune
2020-11-02
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Nagpur, Hyderabad, Bangalore, Lucknow, Manipal, Nashik, Pune, Surat
2020-10-15
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Hyderabad, Kolkata, Mumbai, Nashik, New Delhi, Pune
2020-10-13
Active, closed
Acerta Pharma BV
Phase 3
611
Bangalore, Delhi, Kochi, Mumbai, Nashik, Pune
2020-10-08
Recruiting
International Agency for Research on Cancer
Observational
5,500
Gangtok
2020-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Hyderabad, Kolkata, Mumbai, Nashik, Pune
2020-09-30
Active, closed
AstraZeneca
Phase 2
30
Delhi, Mumbai
2020-09-28
Recruiting
Epygenix
Phase 3
150
Hyderabad, Surat, Belagavi, Bengaluru, Kochi, Pune, Mumbai, Nagpur
2020-09-15
Active, closed
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Ovarian Cancer, Ovarian Serous Adenocarcinoma
DrugsOregovomab·Paraplatin·Taxol·Paclitaxel
CanariaBio Inc.
Phase 3
615
Bangalore, Bengaluru, Delhi, Mohali, Mumbai, Noida, Pune
2020-08-25
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Delhi, Gūrgaon, Kolkata, Mumbai
2020-08-18
Recruiting
Tata Memorial Centre
Not applicable
30
Mumbai
2020-08-13
Recruiting
AutoInflammatory Disease Alliance Registry (AIDA)
NCT05200715Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome
University of Siena
Observational
3,500
Bangalore, Chandigarh
2020-08-06
Active, closed
MINIject Global Long-Term Follow-up Study
NCT04524416Open Angle Glaucoma, Ocular Hypertension
iSTAR Medical
Observational
116
Hyderabad
2020-08-05
Active, closed
AstraZeneca
Phase 3
866
Bengaluru, Calicut, Kolkata, Marg Jaipur, New Delhi, Surat, Thiruvananthapuram
2020-07-24
Active, closed
AstraZeneca
Phase 3
134
Ahmedabad, Ajmer, Delhi
2020-07-20
Rows per page Showing 501–1000 of 1122
Previous 1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site. Derived from ClinicalTrials.gov. Retrieved 6 November 2026. https://priyalifescience.com/clinical-trials-india?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,122 studies in total at the last sync on 06 Nov 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in India?

608 of the 1,122 studies in this register are recruiting new participants as of the 06 Nov 2026, 03:16 UTC sync. A further 157 have not yet opened recruitment, 332 are active but closed to new participants, and 25 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (19) Obesity (19) Carcinoma, Non-Small-Cell Lung (15) Heart Failure (14) Overweight (14) Non-Small Cell Lung Cancer (11) Cervical Cancer (11) Liver Cirrhosis (10) Diabetes Mellitus, Type 2 (10) Chronic Kidney Disease (9) Schizophrenia (8) Multiple Myeloma (8) Ulcerative Colitis (8) Non-small Cell Lung Cancer (7) Coronary Artery Disease (7)
→

Browse trials by site location

New Delhi (340) Mumbai (261) Hyderabad (233) Bangalore (199) Pune (186) Kolkata (170) Ahmedabad (159) Nagpur (128) Chandigarh (108) Jaipur (102) Nashik (102) Delhi (98) Belagavi (96) Chennai (91) Bengaluru (87)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.